NYU Langone


 

ASCO GI 2023 Preliminary Efficacy and Correlative Results of the Phase II Trial HCRN GI16-288: Perioperative CV301 Vaccination in Combination With Nivo and Systemic Chemo for Resectable Hepatic-Limited mCRC

96 views
February 23, 2023
Comments 0
Login to view comments. Click here to Login